You searched for "referral"

1684 results found

Intraocular lens technology to deliver enhanced optical performance after cataract refractive surgery

Modern cataract surgery aims to provide patients with the best possible visual outcome with the least dependence on spectacles and minimal or no complications and to treat both cataract and refractive errors with a single procedure. Phacoemulsification is the standard...

The science of glaucoma management: highlights of the 2020 Moorfields International Glaucoma Symposium

Held earlier this year, the 12th annual Moorfields International Glaucoma Symposium provided a forum for advanced clinical and scientific exchange in glaucoma management. The authors describe the key presentation themes and debates, highlighting specific topics of interest to glaucoma specialists....

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

The Eye: A Very Short Introduction

I am a big fan of the ‘Very Short Introductions’ series and find them a great way to gain a basic understanding of several topics, ranging from science to philosophy. The Eye: A Very Short Introduction is no exception. It...

Broadening horizons in ophthalmology: crafting a varied elective experience

The elective period for medical students is a unique opportunity to immerse oneself in a field of interest. For students interested in ophthalmology, this can offer a dedicated experience for what can otherwise be quite limited through undergraduate rotations. Alongside...

Regulatory approval for the use of AI as a medical device

A study led by researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology examined 36 ‘artificial intelligence as a medical device’ tools approved by regulators in Australia, Europe and the US, identifying that 19% had no published peer-reviewed data...

The Haag-Streit ‘Slit Lamp Imaging Competition 2026’ returns for its eighth year

Haag-Streit UK, a leading distributor of ophthalmic diagnostic devices, surgical microscopes, and virtual reality-based medical simulators, announces the reopening of the Haag-Streit annual ‘Slit Lamp Imaging Competition’, now entering its eighth consecutive year. Established as a global platform for clinical...

Diary from my elective: a Parisian experience

The author explains how a research institute’s dedication to multidisciplinary collaboration helped him to discover a passion for academic ophthalmology. The elective aspect to the final year of a medical degree, through its change of scenery and immersion into another...

Eyecare education in times of COVID-19

A collaboration between the German Committee for the Prevention of Blindness (DKVB), Rukwa regional government in Tanzania and the University of St Andrews Global Health Team successfully delivered a hybrid teaching programme for ophthalmic nurses in Sumbawanga, south west Tanzania,...

Optic nerve swelling – your survival guide (part 2)

In this second article we will discuss bilateral optic nerve swelling, its aetiology, various investigations and possible treatments. We will also discuss various protocols used in the management of suspected optic nerve swelling cases. (Part one of this topic available...

Haag-Streit’s 'Slit Lamp Imaging Competition 2024' includes new video category

Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is delighted to launch the Haag-Streit 'Slit Lamp Imaging Competition' in the UK once again.

IAPB brings sector together in Mexico to transform the future of global eye health

The International Agency for the Prevention of Blindness (IAPB) has brought together over 600 delegates, in person and online, for 2030 IN SIGHT LIVE in Mexico City.